Vortioxetine Hydrobromide Monohydrate is a multimodal antidepressant used to treat major depressive disorder. Classified as a serotonin modulator, this pharmaceutical agent works by inhibiting serotonin… Read more
Vortioxetine Hydrobromide Monohydrate is a multimodal antidepressant used to treat major depressive disorder. Classified as a serotonin modulator, this pharmaceutical agent works by inhibiting serotonin reuptake while simultaneously acting as an antagonist at several neurotransmitter receptors, including 5-HT3, 5-HT7, and NMDA. This category contains high-quality reference standards for the active pharmaceutical ingredient, as well as a comprehensive selection of pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these materials for rigorous analytical testing, including impurity profiling, method validation, and ongoing quality control. By providing these specific analytical standards, researchers and quality assurance teams can accurately identify and quantify potential degradants and metabolic products to ensure regulatory compliance and maintain the highest safety standards in drug development and manufacturing processes.